Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects

scientific article published in November 1994

Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CVR/28.11.1662
P698PubMed publication ID7842460

P2093author name stringD J Sheridan
M J Seghatchian
N A Flores
N V Goulielmos
P433issue11
P921main subjectelectrophysiologyQ1154774
P304page(s)1662-1671
P577publication date1994-11-01
P1433published inCardiovascular ResearchQ4642329
P1476titleMyocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects
P478volume28

Reverse relations

cites work (P2860)
Q79369255A new platelet storage lesion index based on paired samples, without and with EDTA and cell counting: comparison of three types of leukoreduced preparations
Q34113027Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
Q50938987Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.
Q35043956Histamine blood concentration in ischemic heart disease patients
Q45226691Histamine contributes to ischemia-related activation of cardiac spinal afferents: role of H1 receptors and PKC.
Q31146533Improvement of postischemic hepatic microcirculation after endothelinA receptor blockade--endothelin antagonism influences platelet-endothelium interactions
Q42944020Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I.
Q28192821NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs
Q34413793Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation
Q41290150Platelet activation during myocardial ischaemia: a contributory arrhythmogenic mechanism
Q41354727Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors
Q73245866Platelet-endothelial cell interactions during hepatic ischemia-reperfusion in vivo: a systematic analysis
Q44103961Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts
Q46865538Protective effects of an inhibitor of glycoprotein IIb/IIIa in the hepatic and pulmonary disturbances secondary to ischemia and reperfusion injury of rat's liver
Q43826635Role of activated platelets in excitation of cardiac afferents during myocardial ischemia in cats
Q26801407The role of platelets in the recruitment of leukocytes during vascular disease
Q37323094Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting